Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Delgocitinib in eyebrow alopecia areata
NCT03325296Phase 2Terminated
- Sponsor
- LEO Pharma
- Start
- Oct 2017
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of delgocitinib in alopecia areata, sponsored by LEO Pharma. Started Oct 2017; status: terminated.
02
Drugs
delgocitinib
03
Conditions
alopecia areata
Beyond the preview
Go deeper on NCT03325296.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03325296.